CellChorus logo

CellChorus

Emerging

Houston biotech with visual AI TIMING platform analyzing individual cell behaviors in nanowell grids; $5.78M raised plus NIH STTR grant targeting CAR-T quality release and drug discovery screening.

30
AI Score
Grade D↑ Trending
AI Visibility Score (Beta)
HealthcareWebsiteUpdated March 2026

Company Overview

About CellChorus

CellChorus is a Houston-based biotechnology company developing the TIMING (Time-lapse Imaging Microscopy in Nanowell Grids) platform — a visual AI system that analyzes individual cell behaviors over time in nanoscale grid arrays to characterize how cells interact, move, and function, enabling drug developers and cell therapy manufacturers to optimize their biologics and cell therapies with unprecedented single-cell resolution. Founded in 2021 and backed with $5.78 million in equity funding plus $3.4 million in non-dilutive grants including a $2.5 million NIH STTR Fast-Track grant in partnership with University of Houston, CellChorus serves biotech researchers, cell therapy manufacturers, and pharmaceutical companies.

Business Model & Competitive Advantage

CellChorus' TIMING platform captures time-lapse microscopy data of individual cells (T-cells, NK cells, CAR-T cells) in nanowell grids and applies computer vision AI to analyze cell-to-cell interactions, killing behaviors, and functional characteristics that static endpoint assays miss. For cell therapy developers (CAR-T, NK cell therapies), this means being able to characterize the potency and killing behavior of manufactured immune cells before infusing them in patients — a quality control capability that current release assays cannot provide. For drug discovery, the platform enables screening drug candidates by their effect on individual cell behavior rather than bulk population averages.

Competitive Landscape 2025–2026

In 2025, CellChorus competes in the cell analysis, bioprocessing analytics, and drug discovery screening market with Sartorius Incucyte (live cell imaging), BioTek Cytation (multimode imaging), and traditional flow cytometry platforms for cell therapy characterization and drug screening. The cell therapy market (CAR-T, NK cell, TIL therapies) has grown significantly with multiple FDA approvals (Kymriah, Yescarta, Carvykti) driving investment in cell therapy manufacturing quality systems. The NIH grant reflects academic validation of the TIMING platform's scientific approach. The 2025 strategy focuses on cell therapy quality release testing partnerships with CDMOs (contract development and manufacturing organizations), expanding the drug discovery screening use case, and building the regulatory science documentation that supports FDA Quality by Design submissions.

Founded
2021
Curated content • Fact-checked and verified

Recent Activity

View all →

Key Differentiators

Emerging Innovator

CellChorus is an emerging player bringing innovative solutions to the Healthcare market.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

30
↑ Trending

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

Browser Use logo

Browser Use

Developer Tools
B2bDeveloper ToolsPlatformSaasStartup

Browser Use is an open-source project that provides a Python library allowing AI agents and large language models to control web browsers as a tool. The library sits between LLM APIs and browser autom

Oracle Health logo

Oracle Health

Healthcare
HealthtechNorth AmericaB2b

Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve

athenahealth logo

athenahealth

Healthcare
B2bCloud NativeEnterpriseErpHealthtechNorth AmericaSaas

athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on

Veeva Systems logo

Veeva Systems

Healthcare Tech
B2bHealthtechSaasPublic

Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv

Idexx Laboratories logo

Idexx Laboratories

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu

Revvity logo

Revvity

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid

Compare CellChorus with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For CellChorus

Claim This Profile

Are you from CellChorus? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim CellChorus Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention CellChorus vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →